102
Views
5
CrossRef citations to date
0
Altmetric
Connective tissue diseases

Intercellular adhesion molecule-1 polymorphisms in patients with Behçet disease: A meta-analysis

&
Pages 481-486 | Received 15 May 2013, Accepted 20 Jun 2013, Published online: 19 Mar 2014

References

  • Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med. 1999;341(17):1284–91.
  • Zouboulis CC, May T. Pathogenesis of Adamantiades-Behcet's disease. Med Microbiol Immunol. 2003;192(3):149–55.
  • Gul A. Behcet's disease: an update on the pathogenesis. Clin Exp Rheumatol. 2001;19(5 Suppl 24):S6–12.
  • Zierhut M, Mizuki N, Ohno S, Inoko H, Gul A, Onoe K, Isogai E. Immunology and functional genomics of Behcet's disease. Cell Mol Life Sci. 2003;60(9):1903–22.
  • Lebedeva T, Dustin ML, Sykulev Y. ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr Opin Immunol. 2005;17(3):251–8.
  • Diamond MS, Staunton DE, Marlin SD, Springer TA. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell. 1991;65(6):961–71.
  • van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med (Berl). 1996;74(1):13–33.
  • Gul A, Esin S, Dilsen N, Konice M, Wigzell H, Biberfeld P. Immunohistology of skin pathergy reaction in Behcet's disease. Br J Dermatol. 1995;132(6):901–7.
  • Aydintug AO, Tokgoz G, Ozoran K, Duzgun N, Gurler A, Tutkak H. Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behcet's disease. Rheumatol Int. 1995;15(2):75–8.
  • Hamzaoui A, Hamzaoui K, Chabbou A, Ayed K. Circulating intercellular adhesion molecules in blood and bronchoalveolar lavage in Behcet's disease. Mediators Inflamm. 1995;4(5):355–8.
  • Verity DH, Wallace GR, Seed PT, Kanawati CA, Ayesh I, Holland-Gladwish J, Stanford MR. Soluble adhesion molecules in Behcet's disease. Ocul Immunol Inflamm. 1998;6(2):81–92.
  • Vora DK, Rosenbloom CL, Beaudet AL, Cottingham RW. Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics. 1994;21(3):473–7.
  • Behar E, Chao NJ, Hiraki DD, Krishnaswamy S, Brown BW, Zehnder JL, Grumet FC. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med. 1996;334(5):286–91.
  • Wenzel K, Ernst M, Rohde K, Baumann G, Speer A. DNA polymorphisms in adhesion molecule genes–a new risk factor for early atherosclerosis. Hum Genet. 1996;97(1):15–20.
  • Boiardi L, Salvarani C, Casali B, Olivieri I, Ciancio G, Cantini F, et al. Intercellular adhesion molecule-1 gene polymorphisms in Behcet's Disease. J Rheumatol. 2001;28(6):1283–7.
  • Ben Dhifallah I, Karray E, Sassi F, Hamzaoui K. Intercellular adhesion molecule 1 K469E gene polymorphism is associated with presence of skin lesions in Tunisian Behcet's disease patients. Tissue Antigens. 2010;75(1):74–8.
  • Chmaisse HN, Fakhoury HA, Salti NN, Makki RF. The ICAM-1 469 T/C gene polymorphism but not 241 G/A is associated with Behcets disease in the Lebanese population. Saudi Med J. 2006;27(5):604–7.
  • Kim EH, Mok JW, Bang DS, Lee ES, Lee SN, Park KS. Intercellular adhesion molecule-1 polymorphisms in Korean patients with Behcet s disease. J Korean Med Sci. 2003;18(3):415–8.
  • Verity DH, Vaughan RW, Kondeatis E, Madanat W, Zureikat H, Fayyad F, et al. Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease. Eur J Immunogenet. 2000;27(2):73–6.
  • Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008–12.
  • Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990;335(8697):1078–80.
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
  • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
  • Chmaisse HN, Fakhoury HA, Salti NN, Makki RF. The ICAM-1 (469 T/C) gene polymorphism but not (241 G/A) is associated with Behcet's disease in the Lebanese population. Neurosciences (Riyadh). 2006;11(3):187–90.
  • Kim EH, Mok JW, Bang D, Lee ES, Lee S, Park KS. The ICAM1469*E is associated with susceptibility to ocular lesions and vasculitis in Korean patients with Behcet's disease. Adv Exp Med Biol. 2003;528:235–6.
  • Saadat M. Association between K469E polymorphism of intracellular adhesion molecules-1 ICAM-1 and Behcet's disease. Saudi Med J. 2006;27(12):1934.
  • Marrosu MG, Ennas MG, Murru MR, Marrosu G, Cianchetti C, Manconi PE. Surface markers on lymphocytes from human cerebrospinal fluid. Identification by monoclonal antibodies. J Neuroimmunol. 1983;5(3):325–31.
  • Iwao M, Morisaki H, Morisaki T. Single-nucleotide polymorphism g.1548G > A (E469K) in human ICAM-1 gene affects mRNA splicing pattern and TPA-induced apoptosis. Biochem Biophys Res Commun. 2004;317(3):729–35.
  • Pola R, Flex A, Gaetani E, Flore R, Serricchio M, Pola P. Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke. 2003;34(4):881–5.
  • Papa A, Pola R, Flex A, Danese S, Armuzzi A, Gaetani E, et al. Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease. Dig Liver Dis. 2004;36(8):528–32.
  • Yang X, Cullen SN, Li JH, Chapman RW, Jewell DP. Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1. J Hepatol. 2004;40(3):375–9.
  • Nejentsev S, Laaksonen M, Tienari PJ, Fernandez O, Cordell H, Ruutiainen J, et al. Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis. Hum Immunol. 2003;64(3):345–9.
  • Ji YN, Wang Q, Zhan P. Intercellular adhesion molecule 1 gene K469E polymorphism is associated with coronary heart disease risk: a meta-analysis involving 12 studies. Mol Biol Rep. 2012;39(5): 6043–8.
  • Bielinski SJ, Reiner AP, Nickerson D, Carlson C, Bailey KR, Thyagarajan B, et al.Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1(sICAM-1). Atherosclerosis. 2011;216(2):390–4.
  • Bielinski SJ, Pankow JS, Li N, Hsu FC, Adar SD, Jenny NS, et al. ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis. 2008;201(2):339–44.
  • Macchioni P, Boiardi L, Casali B, Nicoli D, Farnetti E, Salvarani C. Intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in Italian patients with rheumatoid arthritis. Clin Exp Rheumatol. 2000;18(5):553–8.
  • Salvarani C, Casali B, Boiardi L, Ranzi A, Macchioni P, Nicoli D, et al. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. J Rheumatol. 2000;27(5):1215–21.
  • Yang H, Vora DK, Targan SR, Toyoda H, Beaudet AL, Rotter JI. Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology. 1995; 109(2):440–8.
  • Braun C, Zahn R, Martin K, Albert E, Folwaczny C. Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status. Clin Immunol. 2001; 101(3):357–60.
  • Coll-Vinent B, Vilardell C, Font C, Oristrell J, Hernandez-Rodriguez J, Yague J, et al. Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity. Ann Rheum Dis. 1999;58:189–92.
  • Goke M, Hoffmann JC, Evers J, Kruger H, Manns MP. Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease. J Gastroenterol. 1997;32(4):480–6.
  • Littler AJ, Buckley CD, Wordsworth P, Collins I, Martinson J, Simmons DL. A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol. 1997;36(2):164–9.
  • McLaren AJ, Marshall SE, Haldar NA, Mullighan CG, Fuggle SV, Morris PJ, Welsh KI. Adhesion molecule polymorphisms in chronic renal allograft failure. Kidney Int. 1999;55(5):1977–82.
  • Hirv K, Seyfarth M, Uibo R, Kull K, Salupere R, Latza U, Rink L. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers. Scand J Gastroenterol. 1999;34(10):1025–32.
  • Mycko MP, Kwinkowski M, Tronczynska E, Szymanska B, Selmaj KW. Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol. 1998;44(1):70–5.
  • Gencik M, Meller S, Borgmann S, Sitter T, Menezes Saecker AM, Fricke H, Epplen JT. The association of CD18 alleles with anti-myeloperoxidase subtypes of ANCA-associated systemic vasculitides. Clin Immunol. 2000;94(1):9–12.
  • Nishimura M, Obayashi H, Maruya E, Ohta M, Tegoshi H, Fukui M, et al. Association between type 1 diabetes age-at-onset and intercellular adhesion molecule-1 (ICAM-1) gene polymorphism. Hum Immunol. 2000;61(5):507–10.
  • , Genomes Project ConsortiumAbecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, et al.A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061–73.
  • , International HapMap 3 ConsortiumAltshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA, Peltonen L, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467:52–8.
  • Ben Dhifallah I, Houman H, Khanfir M, Hamzaoui K. Endothelial nitric oxide synthase gene polymorphism is associated with Behcet's disease in Tunisian population. Hum Immunol. 2008; 69(10):661–5.
  • Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54(3):213–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.